HEADER HYDROLASE/HYDROLASE INHIBITOR 14-OCT-11 3U7S TITLE HIV PR DRUG RESISTANT PATIENT'S VARIANT IN COMPLEX WITH DARUNAVIR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POL POLYPROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 9-107; COMPND 5 SYNONYM: HIV PROTEASE; COMPND 6 EC: 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11676; SOURCE 5 GENE: POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24A KEYWDS DARUNVIR, RESISTANCE, MUTATION SCORE, HIV PROTEASE, TMC-114, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.G.SASKOVA,P.REZACOVA,J.KONVALINKA,J.BRYNDA,M.KOZISEK REVDAT 3 28-FEB-24 3U7S 1 REMARK SEQADV HETSYN REVDAT 2 14-MAR-18 3U7S 1 REMARK SEQADV REVDAT 1 18-JAN-12 3U7S 0 SPRSDE 18-JAN-12 3U7S 3GGT JRNL AUTH K.G.SASKOVA,M.KOZISEK,P.REZACOVA,J.BRYNDA,T.YASHINA, JRNL AUTH 2 R.M.KAGAN,J.KONVALINKA JRNL TITL MOLECULAR CHARACTERIZATION OF CLINICAL ISOLATES OF HUMAN JRNL TITL 2 IMMUNODEFICIENCY VIRUS RESISTANT TO THE PROTEASE INHIBITOR JRNL TITL 3 DARUNAVIR. JRNL REF J.VIROL. V. 83 8810 2009 JRNL REFN ISSN 0022-538X JRNL PMID 19535439 JRNL DOI 10.1128/JVI.00451-09 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 10994 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 553 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.10 REMARK 3 REFLECTION IN BIN (WORKING SET) : 813 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.65 REMARK 3 BIN R VALUE (WORKING SET) : 0.2200 REMARK 3 BIN FREE R VALUE SET COUNT : 37 REMARK 3 BIN FREE R VALUE : 0.3100 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1518 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 173 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.281 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.228 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.170 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.913 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.882 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1707 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2338 ; 1.787 ; 2.027 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 215 ;11.756 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 63 ;42.789 ;24.921 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 275 ;13.443 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;15.438 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 275 ; 0.115 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1267 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 850 ; 0.227 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1142 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 159 ; 0.187 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 54 ; 0.223 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.174 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1062 ; 0.942 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1693 ; 1.187 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 728 ; 1.842 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 642 ; 2.587 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 9 REMARK 3 RESIDUE RANGE : A 86 A 99 REMARK 3 ORIGIN FOR THE GROUP (A): -19.0100 27.3790 25.8550 REMARK 3 T TENSOR REMARK 3 T11: -0.0196 T22: -0.0356 REMARK 3 T33: -0.0564 T12: 0.0163 REMARK 3 T13: 0.0249 T23: 0.0148 REMARK 3 L TENSOR REMARK 3 L11: 2.2429 L22: 0.7488 REMARK 3 L33: 8.0029 L12: 0.5545 REMARK 3 L13: -1.8282 L23: -1.2822 REMARK 3 S TENSOR REMARK 3 S11: 0.2068 S12: -0.0052 S13: 0.2568 REMARK 3 S21: 0.1274 S22: 0.0644 S23: 0.2402 REMARK 3 S31: -0.6528 S32: -0.4232 S33: -0.2712 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 10 A 32 REMARK 3 RESIDUE RANGE : A 63 A 85 REMARK 3 ORIGIN FOR THE GROUP (A): -20.4850 16.8750 18.2940 REMARK 3 T TENSOR REMARK 3 T11: -0.0746 T22: -0.0540 REMARK 3 T33: -0.1112 T12: 0.0001 REMARK 3 T13: -0.0102 T23: 0.0059 REMARK 3 L TENSOR REMARK 3 L11: 6.0431 L22: 1.3493 REMARK 3 L33: 2.6167 L12: 1.3593 REMARK 3 L13: 0.3159 L23: 1.0758 REMARK 3 S TENSOR REMARK 3 S11: 0.0492 S12: 0.0326 S13: -0.0692 REMARK 3 S21: -0.0971 S22: -0.1033 S23: 0.1539 REMARK 3 S31: 0.0330 S32: -0.0868 S33: 0.0540 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 33 A 62 REMARK 3 ORIGIN FOR THE GROUP (A): -11.794 9.801 13.176 REMARK 3 T TENSOR REMARK 3 T11: 0.0470 T22: 0.0842 REMARK 3 T33: 0.0763 T12: -0.0090 REMARK 3 T13: -0.0380 T23: -0.1667 REMARK 3 L TENSOR REMARK 3 L11: 5.3988 L22: 3.7893 REMARK 3 L33: 6.2350 L12: -1.9917 REMARK 3 L13: 1.7798 L23: -0.3104 REMARK 3 S TENSOR REMARK 3 S11: 0.3186 S12: 0.7302 S13: -0.8160 REMARK 3 S21: -0.2771 S22: -0.0185 S23: 0.1392 REMARK 3 S31: 0.7511 S32: 0.1350 S33: -0.3001 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 9 REMARK 3 RESIDUE RANGE : B 86 B 99 REMARK 3 ORIGIN FOR THE GROUP (A): -14.2260 30.1860 28.3860 REMARK 3 T TENSOR REMARK 3 T11: -0.0173 T22: -0.0284 REMARK 3 T33: -0.0327 T12: 0.0296 REMARK 3 T13: 0.0096 T23: 0.0132 REMARK 3 L TENSOR REMARK 3 L11: 1.4451 L22: 0.9116 REMARK 3 L33: 8.2175 L12: 0.9178 REMARK 3 L13: -1.3632 L23: -1.4240 REMARK 3 S TENSOR REMARK 3 S11: 0.0739 S12: 0.0931 S13: 0.3575 REMARK 3 S21: 0.0738 S22: -0.0513 S23: 0.0543 REMARK 3 S31: -0.6645 S32: -0.3648 S33: -0.0226 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 10 B 32 REMARK 3 RESIDUE RANGE : B 63 B 85 REMARK 3 ORIGIN FOR THE GROUP (A): -4.3420 26.1640 35.9730 REMARK 3 T TENSOR REMARK 3 T11: -0.0545 T22: -0.0847 REMARK 3 T33: -0.1252 T12: -0.0125 REMARK 3 T13: -0.0115 T23: -0.0188 REMARK 3 L TENSOR REMARK 3 L11: 4.7464 L22: 3.6294 REMARK 3 L33: 2.1524 L12: 2.9870 REMARK 3 L13: 0.3198 L23: -0.2789 REMARK 3 S TENSOR REMARK 3 S11: -0.0685 S12: -0.0415 S13: 0.1079 REMARK 3 S21: 0.1231 S22: 0.0144 S23: -0.0787 REMARK 3 S31: -0.0852 S32: 0.0852 S33: 0.0542 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 33 B 62 REMARK 3 ORIGIN FOR THE GROUP (A): -2.239 15.145 40.757 REMARK 3 T TENSOR REMARK 3 T11: 0.0032 T22: 0.0096 REMARK 3 T33: 0.0609 T12: 0.0109 REMARK 3 T13: 0.0263 T23: 0.0466 REMARK 3 L TENSOR REMARK 3 L11: 1.5102 L22: 3.4159 REMARK 3 L33: 10.1935 L12: 2.1637 REMARK 3 L13: 3.9146 L23: 5.4882 REMARK 3 S TENSOR REMARK 3 S11: -0.0803 S12: 0.3068 S13: -0.1777 REMARK 3 S21: -0.5154 S22: 1.0062 S23: -0.6286 REMARK 3 S31: -0.5796 S32: 1.6594 S33: -0.9259 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3U7S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-OCT-11. REMARK 100 THE DEPOSITION ID IS D_1000068413. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11575 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 45.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC 5.2.0019 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 5MG/ML, INHIBITOR:PROTEIN = REMARK 280 5:1, RESERVOIR: 0.6M NACL, 0.1M MES, DROPS: 2+1UL, PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.54667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 55.09333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 41.32000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 68.86667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 13.77333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 CYS B 67 CA CB SG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O MET A 46 O HOH A 394 1.99 REMARK 500 O10 017 A 201 O HOH A 373 2.01 REMARK 500 O10 017 A 202 O HOH A 373 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 67 CB CYS B 67 SG 0.148 REMARK 500 CYS B 67 CA CYS B 67 C 0.169 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE A 47 N - CA - C ANGL. DEV. = 22.7 DEGREES REMARK 500 GLY B 16 N - CA - C ANGL. DEV. = -15.8 DEGREES REMARK 500 CYS B 67 CB - CA - C ANGL. DEV. = 10.1 DEGREES REMARK 500 CYS B 67 N - CA - CB ANGL. DEV. = 9.3 DEGREES REMARK 500 CYS B 67 CA - CB - SG ANGL. DEV. = 6.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 79 107.07 -55.12 REMARK 500 CYS B 67 -121.44 57.23 REMARK 500 CYS B 67 -123.10 62.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 46 ILE A 47 119.73 REMARK 500 GLY A 52 PHE A 53 33.03 REMARK 500 VAL B 15 GLY B 16 -45.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 BME A 203 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 017 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 017 A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME B 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GGU RELATED DB: PDB DBREF 3U7S A 1 99 UNP Q993Q5 Q993Q5_9HIV1 9 107 DBREF 3U7S B 1 99 UNP Q993Q5 Q993Q5_9HIV1 9 107 SEQADV 3U7S LEU A 10 UNP Q993Q5 ILE 18 ENGINEERED MUTATION SEQADV 3U7S VAL A 12 UNP Q993Q5 THR 20 ENGINEERED MUTATION SEQADV 3U7S ILE A 32 UNP Q993Q5 VAL 40 ENGINEERED MUTATION SEQADV 3U7S PHE A 33 UNP Q993Q5 LEU 41 ENGINEERED MUTATION SEQADV 3U7S THR A 43 UNP Q993Q5 LYS 51 ENGINEERED MUTATION SEQADV 3U7S LEU A 54 UNP Q993Q5 VAL 62 ENGINEERED MUTATION SEQADV 3U7S ASN A 55 UNP Q993Q5 LYS 63 ENGINEERED MUTATION SEQADV 3U7S VAL A 72 UNP Q993Q5 ILE 80 ENGINEERED MUTATION SEQADV 3U7S ILE A 77 UNP Q993Q5 VAL 85 ENGINEERED MUTATION SEQADV 3U7S LEU A 82 UNP Q993Q5 VAL 90 ENGINEERED MUTATION SEQADV 3U7S VAL A 89 UNP Q993Q5 LEU 97 ENGINEERED MUTATION SEQADV 3U7S LEU B 10 UNP Q993Q5 ILE 18 ENGINEERED MUTATION SEQADV 3U7S VAL B 12 UNP Q993Q5 THR 20 ENGINEERED MUTATION SEQADV 3U7S ILE B 32 UNP Q993Q5 VAL 40 ENGINEERED MUTATION SEQADV 3U7S PHE B 33 UNP Q993Q5 LEU 41 ENGINEERED MUTATION SEQADV 3U7S THR B 43 UNP Q993Q5 LYS 51 ENGINEERED MUTATION SEQADV 3U7S LEU B 54 UNP Q993Q5 VAL 62 ENGINEERED MUTATION SEQADV 3U7S ASN B 55 UNP Q993Q5 LYS 63 ENGINEERED MUTATION SEQADV 3U7S VAL B 72 UNP Q993Q5 ILE 80 ENGINEERED MUTATION SEQADV 3U7S ILE B 77 UNP Q993Q5 VAL 85 ENGINEERED MUTATION SEQADV 3U7S LEU B 82 UNP Q993Q5 VAL 90 ENGINEERED MUTATION SEQADV 3U7S VAL B 89 UNP Q993Q5 LEU 97 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL VAL VAL SEQRES 2 A 99 LYS VAL GLY GLY GLN LEU MET GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR ILE PHE GLU GLU MET ASN LEU PRO SEQRES 4 A 99 GLY ARG TRP THR PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE LEU ASN VAL ARG GLN TYR ASP GLN VAL PRO ILE GLU SEQRES 6 A 99 ILE CYS GLY HIS LYS VAL VAL SER THR VAL LEU ILE GLY SEQRES 7 A 99 PRO THR PRO LEU ASN VAL ILE GLY ARG ASN VAL MET THR SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL VAL VAL SEQRES 2 B 99 LYS VAL GLY GLY GLN LEU MET GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR ILE PHE GLU GLU MET ASN LEU PRO SEQRES 4 B 99 GLY ARG TRP THR PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE LEU ASN VAL ARG GLN TYR ASP GLN VAL PRO ILE GLU SEQRES 6 B 99 ILE CYS GLY HIS LYS VAL VAL SER THR VAL LEU ILE GLY SEQRES 7 B 99 PRO THR PRO LEU ASN VAL ILE GLY ARG ASN VAL MET THR SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE HET 017 A 201 38 HET 017 A 202 38 HET BME A 203 2 HET BME B 101 4 HETNAM 017 (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3- HETNAM 2 017 [[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2- HETNAM 3 017 HYDROXYPROPYLCARBAMATE HETNAM BME BETA-MERCAPTOETHANOL HETSYN 017 DARUNAVIR; TMC114; UIC-94017 FORMUL 3 017 2(C27 H37 N3 O7 S) FORMUL 5 BME 2(C2 H6 O S) FORMUL 7 HOH *173(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLY B 86 THR B 91 1 6 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 A 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 B 8 THR A 43 ILE A 47 0 SHEET 2 B 8 LEU A 54 ILE A 66 -1 O GLN A 58 N THR A 43 SHEET 3 B 8 HIS A 69 ILE A 77 -1 O VAL A 71 N ILE A 64 SHEET 4 B 8 ILE A 32 PHE A 33 1 N PHE A 33 O LEU A 76 SHEET 5 B 8 VAL A 84 ILE A 85 -1 O VAL A 84 N ILE A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 VAL A 15 -1 N VAL A 13 O MET A 20 SHEET 8 B 8 LEU A 54 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 8 THR B 43 GLY B 49 0 SHEET 2 C 8 GLY B 52 ILE B 66 -1 O VAL B 56 N LYS B 45 SHEET 3 C 8 HIS B 69 ILE B 77 -1 O VAL B 75 N TYR B 59 SHEET 4 C 8 ILE B 32 PHE B 33 1 N PHE B 33 O LEU B 76 SHEET 5 C 8 VAL B 84 ILE B 85 -1 O VAL B 84 N ILE B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 C 8 LEU B 10 VAL B 15 -1 N VAL B 13 O MET B 20 SHEET 8 C 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 CISPEP 1 VAL B 15 GLY B 16 0 -29.50 SITE 1 AC1 16 ASP A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC1 16 ASP A 30 GLY A 48 ILE A 50 017 A 202 SITE 3 AC1 16 HOH A 373 ASP B 25 GLY B 27 ASP B 30 SITE 4 AC1 16 GLY B 48 GLY B 49 PRO B 81 LEU B 82 SITE 1 AC2 19 ASP A 25 GLY A 27 ASP A 30 ILE A 47 SITE 2 AC2 19 GLY A 48 GLY A 49 ILE A 50 PRO A 81 SITE 3 AC2 19 LEU A 82 017 A 201 HOH A 373 HOH A 376 SITE 4 AC2 19 ASP B 25 GLY B 27 ALA B 28 ASP B 29 SITE 5 AC2 19 ASP B 30 GLY B 49 ILE B 50 SITE 1 AC3 2 CYS A 67 GLY B 68 SITE 1 AC4 4 GLY A 68 ILE B 3 VAL B 11 CYS B 67 CRYST1 62.540 62.540 82.640 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015990 0.009232 0.000000 0.00000 SCALE2 0.000000 0.018463 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012101 0.00000